Developing NICE diagnostic technologies guidance
This is a summary of how NICE develops guidance through the Diagnostics Assessment (DA) Programme. Diagnostics guidance may cover a single diagnostic technology or product, or more than one diagnostic technology or product. See all diagnostic assessments currently in development.
1. Assessment topics chosen
NICE's Medical Technologies Advisory Committee selects topics for assessment by the DA programme. Read more about how medical technology topics are chosen.
2. Stakeholders invited to register
National organisations representing patients and carers, and also health professionals involved in their care can register as stakeholders. Stakeholders are consulted throughout the assessment process. Read more about stakeholder registration.
3. Scope prepared
The scope defines the disease(s), the patients and the technology(ies) covered by the assessment and the questions it aims to answer. NICE registered stakeholders and specialist committee members can all contribute to the development of the scope.
4. Specialist Committee members recruited
The Diagnostics Advisory Committee is an independent advisory committee. Specialist members with expert knowledge of the subject are recruited to the Committee for the duration of the assessment. Find out about current opportunities.
5. Information provided by manufacturers
NICE invites manufacturer(s) of the technology being assessed, to provide relevant published and unpublished information and data to the assessment.
6. Diagnostics assessment report (DAR) prepared
NICE commissions an independent academic centre to review the evidence on the technology and prepare the diagnostic assessment report. Registered stakeholders are invited to comment on the report.
7. Diagnostics Advisory Committee meeting
An independent advisory committee considers the evaluation report and formulates draft recommendations. The Committee discussions are held in public. Read more about the Diagnostics Advisory Committee
8. Diagnostic consultation document (DCD) produced
The advisory committee makes its provisional recommendations in the DCD. Registered stakeholders have 4 weeks to comment on the DCD. The DCD is also made available on our website so health professionals and members of the public can comment on it.
9. Final guidance produced
The Committee considers the comments received on the DCD then makes its final recommendations on how the technology should be used in the NHS in England and Wales.
Once NICE formally approves the final guidance, individuals or organisations who commented on the draft guidance are notified. They can request corrections to the guidance due to breach of process or factual errors.
11. Guidance issued
If there are no resolution requests, NICE Issues its guidance to the NHS.
This page was last updated: 17 May 2012